HOLMAN, Rury R.: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Time-varying risk of microvascular complications in latent autoimmune diabetes of adulthood compared with type 2 diabetes in adults: a post-hoc analysis of the UK Prospective Diabetes Study 30-year follow-up data (UKPDS 86)

Maddaloni, Ernesto, Coleman, Ruth L, Agbaje, Olorunsola, Buzzetti, Raffaella, Holman, Rury R

Journal:

The Lancet Diabetes & Endocrinology

Year:

2020

Language:

english

File:

PDF, 402 KB

english, 2020

2

The impact of individualised cardiovascular disease (CVD) risk estimates and lifestyle advice on physical activity in individuals at high risk of CVD: a pilot 2 × 2 factorial understanding risk trial

Hermione C Price, Lynne Tucker, Simon J Griffin, Rury R Holman

Journal:

Cardiovascular Diabetology

Year:

2008

Language:

english

File:

PDF, 214 KB

english, 2008

3

Life-expectancy projection by modelling and computer simulation (UKPDS 46)

Richard Stevens, Amanda Adler, Alastair Gray, Andrew Briggs, Rury Holman

Journal:

Diabetes Research and Clinical Practice

Year:

2000

Language:

english

File:

PDF, 131 KB

english, 2000

4

10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes

Holman, Rury R., Paul, Sanjoy K., Bethel, M. Angelyn, Matthews, David R., Neil, H. Andrew W.

Journal:

Boston Medical and Surgical Journal

Year:

2008

Language:

english

File:

PDF, 579 KB

english, 2008

5

Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial

Preiss, David, Lloyd, Suzanne M, Ford, Ian, McMurray, John J, Holman, Rury R, Welsh, Paul, Fisher, Miles, Packard, Chris J, Sattar, Naveed

Journal:

The Lancet Diabetes & Endocrinology

Year:

2014

Language:

english

File:

PDF, 259 KB

english, 2014

6

Long-Term Follow-up after Tight Control of Blood Pressure in Type 2 Diabetes

Holman, Rury R., Paul, Sanjoy K., Bethel, M. Angelyn, Neil, H. Andrew W., Matthews, David R.

Journal:

Boston Medical and Surgical Journal

Year:

2008

Language:

english

File:

PDF, 554 KB

english, 2008

7

Potential impact of omega-3 treatment on cardiovascular disease in type 2 diabetes

Hartweg, Janine, Farmer, Andrew J, Holman, Rury R, Neil, Andrew

Journal:

Current Opinion in Lipidology

Year:

2009

Language:

english

File:

PDF, 181 KB

english, 2009

8

Management of T2DM in 2017: Clinically relevant results from cardiovascular outcome trials

Holman, Rury R.

Journal:

Nature Reviews Endocrinology (formerly Nature Clinical Practice Endocrinology & Metabolism)

Year:

2018

Language:

english

File:

PDF, 215 KB

english, 2018

9

Effect of race on the glycaemic response to sitagliptin: Insights from the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)

Davis, Timothy M. E., Mulder, Hillary, Lokhnygina, Yuliya, Aschner, Pablo, Chuang, Lee-Ming, Raffo Grado, Carlos A., Standl, Eberhard, Peterson, Eric D., Holman, Rury R.

Journal:

Diabetes, Obesity and Metabolism

Year:

2018

Language:

english

File:

PDF, 1.25 MB

english, 2018

10

What does the Acarbose Cardiovascular Evaluation (ACE) trial tell us?

Holman, Rury R.

Journal:

Journal of Diabetes

Year:

2018

Language:

english

File:

PDF, 105 KB

english, 2018

11

A1C Targets Should Be Personalized to Maximize Benefits While Limiting Risks

Riddle, Matthew C., Gerstein, Hertzel C., Holman, Rury R., Inzucchi, Silvio E., Zinman, Bernard, Zoungas, Sophia, Cefalu, William T.

Journal:

Year:

2018

Language:

english

File:

PDF, 625 KB

english, 2018

12

Antithrombotic treatment gap among patients with atrial fibrillation and type 2 diabetes

Guimarães, Patrícia O., Peterson, Eric D., Stevens, Susanna R., Lokhnygina, Yuliya, Green, Jennifer B., McGuire, Darren K., Holman, Rury R., Lopes, Renato D.

Journal:

International Journal of Cardiology

Year:

2019

Language:

english

File:

PDF, 340 KB

english, 2019

13

Associations between beta-blocker therapy and cardiovascular outcomes in patients with diabetes and established cardiovascular disease

Shavadia, Jay S., Zheng, Yinggan, Green, Jennifer B., Armstrong, Paul W., Westerhout, Cynthia M., McGuire, Darren K., Cornel, Jan H., Holman, Rury R., Peterson, Eric D.

Journal:

American Heart Journal

Year:

2019

Language:

english

File:

PDF, 1.79 MB

english, 2019

14

Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64)

Adler, Amanda I, Stevens, Richard J, Manley, Sue E, Bilous, Rudy W, Cull, Carole A, Holman, Rury R

Journal:

Kidney International

Year:

2003

Language:

english

File:

PDF, 150 KB

english, 2003

15

Challenges of maintaining research protocol fidelity in a clinical care setting: A qualitative study of the experiences and views of patients and staff participating in a randomized controlled trial

Julia Lawton, Nicholas Jenkins, Julie L Darbyshire, Rury R Holman, Andrew J Farmer, Nina Hallowell

Journal:

Year:

2011

Language:

english

File:

PDF, 308 KB

english, 2011

16

Addition of exenatide to insulin therapy in individuals with type 2 diabetes in UK routine clinical practice

Hermione C Price, Catherine Gorst, Usha Ayyagari, Jonathan Levy, Rury R Holman

Journal:

Practical Diabetes

Year:

2012

Language:

english

File:

PDF, 211 KB

english, 2012

17

Hypoglycemia in Type 2 diabetic patients randomized to and maintained on monotherapy with diet, sulfonylurea, metformin, or insulin for 6 years from diagnosis: UKPDS73

Alex D. Wright, Carole A. Cull, Kenneth M. Macleod, Rury R. Holman

Journal:

Journal of Diabetes and its Complications

Year:

2006

Language:

english

File:

PDF, 196 KB

english, 2006

18

Understanding the outcomes of multi-centre clinical trials: A qualitative study of health professional experiences and views

Julia Lawton, Nicholas Jenkins, Julie Darbyshire, Andrew Farmer, Rury Holman, Nina Hallowell

Journal:

Social Science & Medicine

Year:

2012

Language:

english

File:

PDF, 165 KB

english, 2012

19

UKPDS58—modeling glucose exposure as a risk factor for photocoagulation in type 2 diabetes

Richard J. Stevens, Irene M. Stratton, Rury R. Holman

Journal:

Journal of Diabetes and its Complications

Year:

2002

Language:

english

File:

PDF, 147 KB

english, 2002

20

Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Hypertension on Clinical End Points: A Cohort Study

John J.V. McMurray, Robert M. Califf, Angelyn M. Bethel, Steven M. Haffner, Rury R. Holman

Journal:

Journal of Clinical Hypertension

Year:

2012

Language:

english

File:

PDF, 27 KB

english, 2012

21

Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials

Christoph Stettler, Sabin Allemann, Peter Jüni, Carole A. Cull, Rury R. Holman, Matthias Egger, Stephan Krähenbühl, Peter Diem

Journal:

American Heart Journal

Year:

2006

Language:

english

File:

PDF, 220 KB

english, 2006

22

Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: Rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial

Robert M. Califf, Mitradev Boolell, Steven M. Haffner, M. Angelyn Bethel, John McMurray, Anil Duggal, Rury R. Holman

Journal:

American Heart Journal

Year:

2008

Language:

english

File:

PDF, 346 KB

english, 2008

23

Determining the most appropriate components for a composite clinical trial outcome

M. Angelyn Bethel, Rury Holman, Steven M. Haffner, Robert M. Califf, Alice Huntsman-Labed, Tsushung A. Hua, John McMurray

Journal:

American Heart Journal

Year:

2008

Language:

english

File:

PDF, 613 KB

english, 2008

24

Hyperglycemia and hyperinsulinemia at diagnosis of diabetes and their association with subsequent cardiovascular disease in the United Kingdom Prospective Diabetes Study (UKPDS 47)

Amanda I. Adler, H.Andrew W. Neil, Susan E. Manley, Rury R. Holman, Robert C. Turner

Journal:

American Heart Journal

Year:

1999

Language:

english

File:

PDF, 136 KB

english, 1999

25

Fire-and-forget in prevention of coronary heart disease

Fredrik Karpe, Rury Holman

Journal:

Year:

2002

Language:

english

File:

PDF, 48 KB

english, 2002

26

The UK Prospective Diabetes study

Rebert C Turner, Rury Holman, Irene Saration

Journal:

Year:

1998

Language:

english

File:

PDF, 40 KB

english, 1998

27

UKPDS: what was the question?

Robert Turner, Rury Holman, John Butterfield

Journal:

Year:

1999

Language:

english

File:

PDF, 25 KB

english, 1999

28

Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis

Richard Kahn, Peter Alperin, David Eddy, Knut Borch-Johnsen, John Buse, Justin Feigelman, Edward Gregg, Rury R Holman, M Sue Kirkman, Michael Stern, Jaakko Tuomilehto, Nick J Wareham

Journal:

Year:

2010

Language:

english

File:

PDF, 365 KB

english, 2010

29

Is early detection of type 2 diabetes worthwhile?

Stephan Colagiuri, Carole Cull, Rury Holman

Journal:

Diabetes Research and Clinical Practice

Year:

2000

Language:

english

File:

PDF, 210 KB

english, 2000

30

Assessing the potential for α-glucosidase inhibitors in prediabetic states

Journal:

Diabetes Research and Clinical Practice

Year:

1998

Language:

english

File:

PDF, 117 KB

english, 1998

31

Baseline Characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial Population: Comparison with Other Diabetes Prevention Trials

Henry Krum, John J.V. McMurray, Edward Horton, Teresa Gerlock, Bjoern Holzhauer, Lineke Zuurman, Steven M. Haffner, M. Angelyn Bethel, Rury R. Holman, Robert M. Califf

Journal:

Cardiovascular Therapeutics

Year:

2010

Language:

english

File:

PDF, 126 KB

english, 2010

32

Prediabetes and the risk of diabetes

John JV McMurray, Steven M Haffner, Robert M Califf, Rury R Holman

Journal:

Year:

2012

Language:

english

File:

PDF, 78 KB

english, 2012

33

UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes

Robert Turner, Irene Stratton, Virginia Horton, Sue Manley, Paul Zimmet, Ian R Mackay, Marion Shattock, Gian Franco Bottazzo, Rury Holman

Journal:

Year:

1997

Language:

english

File:

PDF, 89 KB

english, 1997

34

Long-term efficacy of sulfonylureas: a United Kingdom Prospective Diabetes Study perspective

Journal:

Year:

2006

Language:

english

File:

PDF, 198 KB

english, 2006

35

Perceptions of heart attack risk amongst individuals with diabetes

Hermione C. Price, Christina Dudley, Beryl Barrow, Simon J. Griffin, Rury R. Holman

Journal:

Primary Care Diabetes

Year:

2009

Language:

english

File:

PDF, 184 KB

english, 2009

36

People at increased risk of cardiovascular disease screened for the NAVIGATOR trial frequently have undiagnosed diabetes or impaired glucose tolerance

Robert M. Califf, Rury Holman

Journal:

Journal of the American College of Cardiology

Year:

2003

Language:

english

File:

PDF, 357 KB

english, 2003

37

Type 2 diabetes mellitus in 2012: Optimal management of T2DM remains elusive

Holman, Rury R.

Journal:

Nature Reviews Endocrinology (formerly Nature Clinical Practice Endocrinology & Metabolism)

Year:

2013

Language:

english

File:

PDF, 191 KB

english, 2013

38

Addition of Biphasic, Prandial, or Basal Insulin to Oral Therapy in Type 2 Diabetes

Holman, Rury R., Thorne, Kerensa I., Farmer, Andrew J., Davies, Melanie J., Keenan, Joanne F., Paul, Sanjoy, Levy, Jonathan C.

Journal:

Boston Medical and Surgical Journal

Year:

2007

Language:

english

File:

PDF, 310 KB

english, 2007

39

Three-Year Efficacy of Complex Insulin Regimens in Type 2 Diabetes

Holman, Rury R., Farmer, Andrew J., Davies, Melanie J., Levy, Jonathan C., Darbyshire, Julie L., Keenan, Joanne F., Paul, Sanjoy K.

Journal:

Boston Medical and Surgical Journal

Year:

2009

Language:

english

File:

PDF, 421 KB

english, 2009

40

Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy

Kahn, Steven E., Haffner, Steven M., Heise, Mark A., Herman, William H., Holman, Rury R., Jones, Nigel P., Kravitz, Barbara G., Lachin, John M., O'Neill, M. Colleen, Zinman, Bernard, Viberti, Giancarl

Journal:

Boston Medical and Surgical Journal

Year:

2006

Language:

english

File:

PDF, 425 KB

english, 2006

41

Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): a cohort analysis

Yates, Thomas, Haffner, Steven M, Schulte, Phillip J, Thomas, Laine, Huffman, Kim M, Bales, Connie W, Califf, Robert M, Holman, Rury R, McMurray, John J V, Bethel, M Angelyn, Tuomilehto, Jaakko, Davie

Journal:

Year:

2014

Language:

english

File:

PDF, 167 KB

english, 2014

42

Rationale, design, and organization of a randomized, controlled Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) in patients with type 2 diabetes and established cardiovascular disease

Green, Jennifer B., Bethel, M. Angelyn, Paul, Sanjoy K., Ring, Arne, Kaufman, Keith D., Shapiro, Deborah R., Califf, Robert M., Holman, Rury R.

Journal:

American Heart Journal

Year:

2013

Language:

english

File:

PDF, 313 KB

english, 2013

43

Rationale for and design of the Acarbose Cardiovascular Evaluation (ACE) trial

Holman, Rury R., Bethel, Mary A., Chan, Juliana C.N., Chiasson, Jean-Louis, Doran, Zoë, Ge, Junbo, Gerstein, Hertzel, Huo, Yong, McMurray, John J., Ryden, Lars, Liyanage, Winitha, Schröder, Stefan, Te

Journal:

American Heart Journal

Year:

2014

Language:

english

File:

PDF, 430 KB

english, 2014

44

Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored

McMurray, John J V, Gerstein, Hertzel C, Holman, Rury R, Pfeffer, Marc A

Journal:

The Lancet Diabetes & Endocrinology

Year:

2014

Language:

english

File:

PDF, 259 KB

english, 2014

45

Incidence of atrial fibrillation in a population with impaired glucose tolerance: The contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial

Latini, Roberto, Staszewsky, Lidia, Sun, Jie-Lena, Bethel, M. Angelyn, Disertori, Marcello, Haffner, Steven M., Holman, Rury R., Chang, Futien, Giles, Thomas D., Maggioni, Aldo P., Rutten, Guy E.H.M.,

Journal:

American Heart Journal

Year:

2013

Language:

english

File:

PDF, 197 KB

english, 2013

46

INTERMEDIATE ACTING INSULIN FOR TYPE 2 DIABETES

Turner, Robert, Holman, Rury, Walworth, DavidH., Mchardy, KennethC.

Journal:

Year:

1985

Language:

english

File:

PDF, 339 KB

english, 1985

47

A Novel Risk Classification Paradigm for Patients With Impaired Glucose Tolerance and High Cardiovascular Risk

Bethel, M. Angelyn, Chacra, Antonio R., Deedwania, Prakash, Fulcher, Gregory R., Holman, Rury R., Jenssen, Trond, Kahn, Steven E., Levitt, Naomi S., McMurray, John J.V., Califf, Robert M., Raptis, Sot

Journal:

The American Journal of Cardiology

Year:

2013

Language:

english

File:

PDF, 119 KB

english, 2013

48

EVALUATION OF A NEW BLOOD GLUCOSE METER

Altman, DouglasG., Matthews, David, Holman, Rury

Journal:

Year:

1987

Language:

english

File:

PDF, 297 KB

english, 1987

49

Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes

Holman, Rury R, Sourij, Harald, Califf, Robert M

Journal:

Year:

2014

Language:

english

File:

PDF, 231 KB

english, 2014

50

Cardiovascular endocrinology: First-time heart failure increases risk of diabetes mellitus

Holman, Rury R.

Journal:

Nature Reviews Endocrinology (formerly Nature Clinical Practice Endocrinology & Metabolism)

Year:

2014

Language:

english

File:

PDF, 549 KB

english, 2014